Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| ElevenLabs | 2026 | Series D | $500.0M | New York |
| Kindred | 2026 | Series C | $85.0M | San Francisco |
| Horizon3.ai | 2026 | Series Unknown | Undisclosed | San Francisco |
| Tulip Interfaces | 2026 | Series D | $120.0M | Somerville |
| Recludix Pharma | 2026 | Undisclosed | Undisclosed | San Diego |
| Wonder | 2026 | Series Unknown | $8.4M | New York |
| Monte Rosa Therapeutics | 2026 | Post Ipo Equity | $300.0M | Basel |
| Cohere Technologies | 2026 | Series Unknown | $15.0M | San Jose |
| H2 | 2025 | Seed | Undisclosed | Tokyo |
| Mirum Pharmaceuticals | 2025 | Post Ipo Equity | $68.5M | Foster City |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 126 | ElevenLabs | Series D | $500.0M | New York, United States |
| 127 | Kindred | Series C | $85.0M | San Francisco, United States |
| 128 | Horizon3.ai | Series Unknown | Undisclosed | San Francisco, United States |
| 129 | Tulip Interfaces | Series D | $120.0M | Somerville, United States |
| 130 | Recludix Pharma | Undisclosed | Undisclosed | San Diego, United States |
| 131 | Wonder | Series Unknown | $8.4M | New York, United States |
| 132 | Monte Rosa Therapeutics | Post Ipo Equity | $300.0M | Basel, Switzerland |
| 133 | Cohere Technologies | Series Unknown | $15.0M | San Jose, United States |
| 134 | H2 | Seed | Undisclosed | Tokyo, Japan |
| 135 | Mirum Pharmaceuticals | Post Ipo Equity | $68.5M | Foster City, United States |
ElevenLabs is an AI company that offers tools for speech synthesis, voice cloning, dubbing, and audio generation.
Kindred operates a members-only platform that enables verified homeowners and renters to exchange homes without nightly rental fees.
Horizon3.ai offers an autonomous penetration testing platform that helps organizations proactively find and fix security vulnerabilities.
Tulip is a frontline operations platform designed to empower companies with AI-enabled, connected applications.
Recludix pharma is a developing platform to treat cancer patients.
Wonder is a food delivery startup that operates truck-based restaurants from which consumers can order food through a mobile app.
Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.
Cohere is a software company focused on mobile technology.
H2 is a technology company that offers AI-driven solutions and software for the construction industry to enhance efficiency in planning.
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.
Mythic develops analog matrix processors and key cards based on analog compute-in-memory.
Wispr Flow develops a voice dictation app that converts speech to text for writing, messaging, and note taking.
Tailor is a no-code headless ERP platform helping retail businesses unify tools, marketplaces, and teams on one system.
Fabric8Labs is a machinery company that specializes in metal 3D printing.
Chaos is a defense technology company that develops advanced sensing, detection, and communication technologies for the military sectors.
Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.
House Rx is a health technology platform focused on improving affordability and patient access to specialty medications.
Popai Health uses care coordination calls to extract important insights.
Kaizen Labs is a software company that helps city administrators transform resident experiences with simple digital products.
Synthesia is an AI video platform that enables users to create videos from text using advanced AI avatars and voiceovers.
Spiras Health is an operator of a healthcare company intended to extend the care of a patient dealing with complex chronic illness.
CoreStory uses generative AI and reusable code to radically accelerate the software development lifecycle.
X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.
IONQ offers enterprise-grade quantum systems designed for businesses seeking to harness the power of quantum computing in their operations.
Twelve Labs is a video intelligence platform that uses AI to analyze and search through video content.
New Enterprise Associates has invested in 461 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
New Enterprise Associates's top investment sectors include Software, Artificial Intelligence (AI), Health Care, Information Technology, Biotechnology. The firm invests across 57 different industry categories.
Among tracked funding rounds, IonQ received $2.0B in a Post Ipo Equity round. New Enterprise Associates's total known invested capital is $23.0B.
New Enterprise Associates's average investment size is $69.4M across its portfolio of 461 companies.
Recent New Enterprise Associates portfolio additions include ElevenLabs, Kindred, Horizon3.ai, Tulip Interfaces, Recludix Pharma. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors